121765 Sigma-AldrichAG 825 - CAS 149092-50-2 - Calbiochem
A potent, cell-premeable, reversible, substrate competitive, and selective inhibitor of HER2 (neu/ErbB2; IC₅₀ = 0.35 µM) relative to HER1 (IC₅₀= 19 µM) autophosphorylation.
More>> A potent, cell-premeable, reversible, substrate competitive, and selective inhibitor of HER2 (neu/ErbB2; IC₅₀ = 0.35 µM) relative to HER1 (IC₅₀= 19 µM) autophosphorylation. Less<<AG 825 - CAS 149092-50-2 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: 4-Hydroxy-3-methoxy-5-(benzothiazolylthiomethyl)benzylidenecyanoacetamide
Recommended Products
概述
Replacement Information |
---|
重要规格表
CAS # | Empirical Formula |
---|---|
149092-50-2 | C₁₉H₁₅N₃O₃S₂ |
Products
产品目录编号 | 包装 | 数量 / 包装 | |
---|---|---|---|
121765-2MGCN | 塑胶安瓿;塑胶针药瓶 | 2 mg |
Product Information | |
---|---|
CAS number | 149092-50-2 |
ATP Competitive | N |
Form | Yellow solid |
Hill Formula | C₁₉H₁₅N₃O₃S₂ |
Chemical formula | C₁₉H₁₅N₃O₃S₂ |
Reversible | Y |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | HER2 |
Primary Target IC<sub>50</sub> | 0.35 µM against HER2 |
Purity | ≥94% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
产品目录编号 | GTIN |
121765-2MGCN | 07790788047917 |
Documentation
AG 825 - CAS 149092-50-2 - Calbiochem MSDS
职位 |
---|
AG 825 - CAS 149092-50-2 - Calbiochem 分析证书
标题 | 批号 |
---|---|
121765 |
参考
参考信息概述 |
---|
Ashton, J.M., et al. 2012. Cell Stem Cell 11, 359. Tsai, C.M., et al. 1996. Cancer Res. 56, 1068. Levitzki, A., and Gazit, A. 1995. Science 267, 1782. Osherov, N., et al. 1993. J. Biol. Chem. 268, 11134. |